|
Volumn 40, Issue 5, 2002, Pages 452-455
|
The effect of N-acetylcysteine supplementation upon viral load, CD4, CD8, total lymphocyte count and hematocrit in individuals undergoing antiretroviral treatment
a a a a a a a a a a a |
Author keywords
Antioxidant; Antiretroviral therapy; HIV; N acetylcysteine
|
Indexed keywords
ACETYLCYSTEINE;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CD8 ANTIGEN;
PLACEBO;
SELENIUM;
ZANBON;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HEMATOCRIT;
HEMATOLOGICAL PARAMETERS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
LYMPHOCYTE COUNT;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VIRUS LOAD;
BLOOD;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CYTOLOGY;
DRUG COMBINATION;
IMMUNOLOGY;
HUMAN IMMUNODEFICIENCY VIRUS;
RNA VIRUSES;
ACETYLCYSTEINE;
ANTI-HIV AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HEMATOCRIT;
HIV INFECTIONS;
HUMANS;
LYMPHOCYTE COUNT;
MALE;
VIRAL LOAD;
|
EID: 18444396890
PISSN: 14346621
EISSN: None
Source Type: Journal
DOI: 10.1515/CCLM.2002.077 Document Type: Article |
Times cited : (18)
|
References (18)
|